SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001214659-22-005918
Filing Date
2022-04-28
Accepted
2022-04-28 07:00:19
Documents
2
Group Members
AULT ALPHA LPAULT LIFE SCIENCES FUND, LLCAULT LIFE SCIENCES, INC.BITNILE HOLDINGS, INC.DAVID J. KATZOFFDIGITAL POWER LENDING, LLCHENRY C.W. NISSERKENNETH S. CRAGUNWILLIAM B. HORNE

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 g427220sc13da2.htm SC 13D/A 210461
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 8462
  Complete submission text file 0001214659-22-005918.txt   220540
Mailing Address 15641 RED HILL AVENUE, SUITE 200 TUSTIN CA 92780
Business Address
AULT MILTON C III (Filed by) CIK: 0001212502 (see all company filings)

State of Incorp.: DE
Type: SC 13D/A

Mailing Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612
Business Address 3802 SPECTRUM BLVD, SUITE C112C TAMPA FL 33612 844-722-6333
Alzamend Neuro, Inc. (Subject) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SC 13D/A | Act: 34 | File No.: 005-92615 | Film No.: 22862113
SIC: 2834 Pharmaceutical Preparations